利多卡因
医学
肺癌
转移
癌症研究
肺
巨噬细胞
呼吸道疾病
药理学
癌症
病理
细胞
拉顿
调制(音乐)
细胞凋亡
免疫学
体内
作者
Zeyu Liu,Jinquan Zhang,Xiaona Chen,Ziqi Sun,Jiabo Chen,Zhixia Chen,Quan Li
标识
DOI:10.1016/j.bja.2025.12.056
摘要
BACKGROUND: Tumour-associated macrophages (TAMs), which are frequently associated with cancer-related death in humans, play crucial roles in the metastasis of tumours, including lung cancer. However, whether lidocaine affects TAMs and exerts antimetastatic effects on non-small cell lung cancer remains unclear. METHODS: Lung cancer cells were treated directly with lidocaine or cocultured with lidocaine-treated TAMs. The effect of lidocaine on lung cancer metastasis was assessed by performing experiments in C57BL/6 mice and BALB/c nude mice in vivo. The migration and proliferation of lung cancer cells were evaluated by wound healing, transwell, and CCK-8 assays. Furthermore, changes in macrophage polarisation were assessed via reverse transcription-quantitative polymerase chain reaction and flow cytometry analysis. RESULTS: Lidocaine suppressed tumour metastasis in C57BL/6 mice (P<0.01) but not in BALB/c nude mice. When macrophages were depleted by clodronate liposomes in C57BL/6 mice, the antimetastatic effect of lidocaine was abrogated. However, the antimetastatic effect of lidocaine was observed in BALB/c nude mice simultaneously injected with both lung cancer cells and TAMs (P<0.001). Lidocaine attenuated the polarisation of TAMs toward the M2b subtype (P<0.05) by inhibition of the activation of the protein kinase B/cAMP-response element binding protein pathway. CONCLUSIONS: Our results indicate that lidocaine attenuates tumour metastasis through modulation of M2b-polarised TAMs in non-small cell lung cancer, providing a mechanistic basis for the potential application of anaesthetics in lung cancer patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI